
The Department of Medical Services (DMS) has admitted that the department has struggled to supply sufficient numbers of Favipiravir pills for the treatment of Covid-19 patients to some areas after the recent surge in cases.
Dr Natthaphong Wongwiwat, deputy director-general of the DMS, said that Favipiravir is currently being both produced and imported by the Government Pharmaceutical Organization (GPO) to meet demand, but the current spike and growing demand for the pills had stretched all available resources at present.